Evaluation of Cerebral Perfusion in Patients Undergoing Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis

about

Evaluation of Cerebral Perfusion in Patients Undergoing Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis

Item

http://www.wikidata.org/entity/Q38586742

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Evaluation of Cerebral Perfusi ...... minogen Activator Thrombolysis

@en

type

Item

label

Evaluation of Cerebral Perfusi ...... minogen Activator Thrombolysis

@en

prefLabel

Evaluation of Cerebral Perfusi ...... minogen Activator Thrombolysis

@en

P1476

Evaluation of Cerebral Perfusi ...... minogen Activator Thrombolysis

@en

P2093

Teruyuki Hirano

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivatives

P2860

Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials

A randomized trial of tenecteplase versus alteplase for acute ischemic stroke

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

CT sign of brain swelling without concomitant parenchymal hypoattenuation: comparison with diffusion- and perfusion-weighted MR imaging.

Population-based study of wake-up strokes.

THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0·6 mg/kg (THAWS) Trial

Negative fluid-attenuated inversion recovery-based intravenous thrombolysis using recombinant tissue plasminogen activator in acute stroke patients with unknown onset time.

Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study.

II. Cerebral infarction/transient ischemic attack (TIA).

Wake-up or unclear-onset strokes: are they waking up to the world of thrombolysis therapy?

P304

789-795

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.2176/NMC.RA.2015-0111

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2015-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282037124

http://www.w3.org/2001/XMLSchema#string

P698

26369875

http://www.w3.org/2001/XMLSchema#string

P921

P932

4663028

http://www.w3.org/2001/XMLSchema#string